ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $267,000 | +2570.0% | 44,235 | +1910.7% | 0.01% | +900.0% |
Q2 2017 | $10,000 | -73.7% | 2,200 | -75.8% | 0.00% | -75.0% |
Q1 2017 | $38,000 | +58.3% | 9,100 | +203.3% | 0.00% | +33.3% |
Q3 2016 | $24,000 | +200.0% | 3,000 | +20.0% | 0.00% | +200.0% |
Q1 2014 | $8,000 | -96.1% | 2,500 | -96.3% | 0.00% | -96.9% |
Q3 2013 | $203,000 | -80.0% | 67,300 | -45.9% | 0.03% | -85.3% |
Q2 2013 | $1,017,000 | -10.2% | 124,332 | -3.9% | 0.22% | +3.3% |
Q1 2013 | $1,132,000 | – | 129,332 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |